Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unilab Chemicals and Pharmaceuticals is a prominent Indian manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, catering to the global pharmaceutical industry. Founded in 1978 and headquartered in Mumbai, the company specializes in the development and large-scale production of small molecule drugs across various therapeutic areas, including diabetes, cardiovascular health, and pain management. Their manufacturing facilities are WHO-GMP certified, ensuring high standards of quality and regulatory compliance for export to international markets. Unilab provides essential bulk drugs such as Metformin, Gliclazide, and Telmisartan to formulation manufacturers worldwide. The company maintains a strong focus on process chemistry and cost-effective manufacturing solutions. With decades of experience, Unilab has established itself as a reliable partner in the pharmaceutical supply chain, supporting both generic and innovator companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unilab Chemicals.